GTC's 9th Anti-infectives Partnering and Deal-Making Conference, taking place on July 9-10, 2012 in San Francisco, CA, will contribute to the on-going battle against the ever-changing infectious threats by having experts with direct experiences in the field discuss a wide variety of topics on infectious diseases. The agenda also allows time for networking and opportunities to interface with speakers and fellow delegates in a collegial setting. Previous GTC conferences have been catalytic to several successful partnerships and in 2012 we expect this trend to continue.

GTC’s Anti-Infectives Partnering & Deal Making is an infectious disease partnering and business development conference that gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, explore potential collaborations, and learn about relevant anti-infective issues and deals that will affect the industry. This event also provides a unique venue for attendees to learn about the anti-infective business development trends, the infectious disease markets, and novel technologies that shape up the industry.

Sessions of the conference include:
Regulatory Guidance and Updates
Models of Deals in Infectious Diseases
Recent Advances in Anti-Infectives Development
Neglected Diseases in the Infectious Diseases Field
Old Drugs, New Drugs
Immunotherapy Approach to Infectious Diseases
Novel Technologies and Diagnostics Against Drug Resistance
Non-dilutive Funding

There will also be several interactive Panel Discussions on:
Current Trends in Anti-infectives Development
Licensing vs Co-development Partnerships
Investments Opportunities in the Anti-Infectives Space
Finding the Middle Ground in Big Pharma and Biotech Partnerships